Reduced heart rate variability predicts progression of coronary artery calcification in adults with type 1 diabetes and controls without diabetes

Diabetes Technology and Therapeutics

Volumn 12, Issue 12, 2010, Pages 963-969

  Rodrigues, Ticiana C ^a,b   Ehrlich, James ^a   Hunter, Cortney M ^a   Kinney, Gregory L ^a   Rewers, Marian ^a   Snell Bergeon, Janet K ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM; CHOLESTEROL; FIBRINOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART RATE VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; RR INTERVAL;

ADULT; CALCINOSIS; CHOLESTEROL; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOGEN; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES; YOUNG ADULT;

EID: 78650144669     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0070     Document Type: Article

References (32)

1. Retnakaran R, Zinman B: Type 1 diabetes, hyperglycaemia, and the heart. Lancet 2008;371:1790-1799.
2. Airaksinem KEJ: Silent coronary artery disease in diabetes\a feature of autonomic neuropathy or accelerated atherosclerosis? Diabetologia 2001;44:259-266.
3. Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH; EURODIAB Prospective Complications Study Group: Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia 2005;48:164-171.
4. Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, Kerényi Z, Tamás G, Ward JD, Fuller JH; EURO-DIAB IDDM Complications Study Group: Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med 2002;19:900-909.
5. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Summary and recommendations. Diabetes Care 1992;15:1104-1107.
6. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF: Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent disease. Eur Heart J 2004;25:363-370.
7. Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G: Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) Study. Hypertension 2003;42:1106-1111.
8. Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, Levy D: Impact of reduced heart rate variability on risk for cardiac events: the Framingham Heart Study. Circulation 1996;94:2850-2855.
9. Gottsäter A, Rydén-Ahlgren A, Szelag B, Hedblad B, Persson J, Berglund G, Wroblewski M, Sundkvist G: Cardiovascular autonomic neuropathy associated with carotid atherosclerosis in type 2 diabetic patients. Diabet Med 2003;20:495-499.
10. Gottsäter A, Ahlgren AR, Taimour S, Sundkvist G: Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes. Clin Auton Res 2006;16:228-234.
11. Raggi P, Callister TQ, Cooil B, He ZX, Lippolis NJ, Russo DJ, Zelinger A, Mahmarian JJ: Identification of patients at increased risk of unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000;101: 850-855.
12. Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, Garg S, Hamman RF, Rewers M; The Coronary Artery Calcification in Type 1 Diabetes Study; Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes 2003;52:2833-2839.
13. Colhoun HM, Francis DP, Rubens MB, Underwood SR, Fuller JH: The association of heart-rate variability with cardiovascular risk factors and coronary artery calcification: a study in type 1 diabetic patients and the general population. Diabetes Care 2001;24:1108-1114.
14. Thilo C, Standl E, Knez A, Reiser M, Steinbeck G, Haberl R, Schnell O: Coronary calcification in long-term Type 1 diabetic patients\a study with multi slice spiral computed tomography. Exp Clin Endocrinol Diabetes 2004;112:561-565.
15. Maahs DM, Ogden LG, Kretowski A, Snell-Bergeon JK, Kinney GL, Berl T, Rewers M: Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with Type 1 diabetes. Diabetes 2007;56:2774-2779.
16. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832.
17. Rautaharju PM, Park LP, Chaitman BR, Rautaharju F, Zhang ZM: The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression. J Electrocardiol 1998;31:157-187.
18. Pitzalis MV, Mastropasqua F, Massari F, Forteo C, Di Maggio M, Passantino A, Colombo R, Di Biase M, Rizzon P: Shortand long-term reproducibility of time and frequency domain heart rate variability measurements in normal subjects. Cardiovasc Res 1996;32:226-233.
19. Hokanson JE, MacKenzie T, Kinney G, Snell-Bergeon JK, Dabelea D, Ehrlich J, Eckel RH, Rewers M: Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR Am J Roentgenol 2004;182:1327-1332.
20. González-Clemente JM, VilardellC,BrochM,MegiaA, Caixàs A, Giménez-Palop O, Richart C, Simón I, Mart́inez-Riquelme A, Arroyo J, Mauricio D, Vendrell J: Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes. Eur J Endocrinol 2007;157:31-38.
21. Maser RE, Pfeifer MA, Dorman JS, Kuller LH, Becker DJ, Orchard TJ: Diabetic autonomic neuropathy and cardiovascular risk. Arch Intern Med 1990;150:1218-1222.
22. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC: C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996;312:1061-1065.
23. Kacem K, Bonvento G, Seylaz J: Effect of sympathectomy on the phenotype of smooth muscle cells of middle cerebral and ear arteries of hyperlipidaemic rabbits. Histochem J 1997; 29:279-286.
24. Sarmento A, Soares-da-Silva P, Teixeira AA, Azevedo I: Effects of denervation induced by 6-hydroxydopamine on cell nucleus activity of arterial and cardiac cells of the dog. J Auton Pharmacol 1987;17:119-126.
25. Lanza GA, Pitocco D, Navarese EP, Sestito A, Sgueglia GA, Manto A, Infusino F, Musella T, Ghirlanda G, Crea F: Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Eur Heart J 2007;28:814-820.
26. Jensen-Urstad M, Jensen-Urstad K, Ericson M, Johansson J: Heart rate variability is related to leucocyte count in men and to blood lipoproteins in women in a healthy population of 35-year-old subjects. J Intern Med 1998;243:33-40.
27. Lampert R, Bremner JD, Su S, Miller A, Lee F, Cheema F, Goldberg J, Vaccarino V: Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J 2008;156:759.e1-e7.
28. Janszky I, Ericson M, Lekander M, Blom M, Buhlin K, Georgiades A, Ahnve S: Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 2004;256:421-428.
29. Lanza GA, Sgueglia GA, Cianflone D, Rebuzzi AG, Angeloni G, Sestito A, Infusino F, Crea F, Maseri A; SPAI (Stratificazione Prognostica dell'Angina Instabile) Investigators: Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol 2006;97:1702-1706.
30. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-462.
31. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003;421: 384-388.
32. Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH; EURODIAB Prospective Complications Study Group: Relationship between risk factors and mortality in type 1 diabetic patients in Europe. The EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008; 31:1360-1366.